Vancomycin-intermediate Staphylococcus aureus

Imported from NNDSS: Vancomycin-intermediate Staphylococcus aureus

0
Countries Affected
No data
Recent Cases (30d)
0
Active Outbreaks
N/A
Last Updated
๐Ÿ“ฑ iOS App Temporarily Unavailable

We're working with Apple to restore our app to the App Store.

Get notified when it's back:
Email [email protected] (subject: REMINDER) or check back in a few days.

Track in App
Temporarily Unavailable
Track in App View Active Outbreaks

What is Vancomycin-intermediate Staphylococcus aureus?

Staphylococcus aureus has long been a significant human pathogen. The emergence of Methicillin-resistant Staphylococcus aureus (MRSA) in the 1960s was a major concern, leading vancomycin to become a critical treatment. The first confirmed case of Vancomycin-intermediate Staphylococcus aureus (VISA) was reported in Japan in 1996, marking a concerning new level of antibiotic resistance and threatening the effectiveness of a key 'last-resort' antibiotic.

Symptoms

  • Skin and soft tissue infections: Redness, swelling, pain, warmth, pus-filled lesions (e.g., boils, abscesses).
  • Systemic infections: Fever, chills, fatigue, weakness (if the bacteria enters the bloodstream, causing sepsis).
  • Other site-specific symptoms: Depending on the infection site (e.g., cough and shortness of breath for pneumonia, bone pain for osteomyelitis).

Transmission

VISA is primarily spread through direct contact with an infected person's wounds, bodily fluids, or contaminated hands. It can also be transmitted indirectly by touching surfaces or objects that have been contaminated with the bacteria. This often occurs in healthcare settings, where bacteria can be transferred via the hands of healthcare workers or shared equipment.

Contagious Period: Varies by disease

Prevention

  • Practice meticulous hand hygiene (washing with soap and water or using alcohol-based hand sanitizer).
  • Avoid sharing personal items like towels, razors, or wound dressings.
  • Keep cuts and scrapes clean and covered with a sterile bandage.
  • Use antibiotics only when prescribed and complete the full course.
  • Adhere to strict infection control measures in healthcare environments (e.g., contact precautions for infected patients).

Active Outbreaks & Recent Cases

Real-time intelligence from global health monitoring and AI-powered surveillance

Data sources: BEACON, ProMED, WHO, CDC, and 50+ national health agencies

No Active Outbreaks Detected

Our AI-powered surveillance hasn't detected significant Vancomycin-intermediate Staphylococcus aureus activity in the past 30 days.

Real-time monitoring continues 24/7 across BEACON, ProMED, WHO, CDC, and 50+ global health agencies

What This Means

Currently, Vancomycin-intermediate Staphylococcus aureus case counts are within baseline expectations globally. However, diseases can emerge rapidly, which is why continuous monitoring is critical.

Stay Prepared

Download the Virus Watcher app to get instant alerts if Vancomycin-intermediate Staphylococcus aureus activity increases in your region or travel destinations.

Prevention Remains Important

Even without active outbreaks, understanding Vancomycin-intermediate Staphylococcus aureus prevention helps protect you and your community:

  • Practice meticulous hand hygiene (washing with soap and water or using alcohol-based hand sanitizer).
  • Avoid sharing personal items like towels, razors, or wound dressings.
  • Keep cuts and scrapes clean and covered with a sterile bandage.
  • Use antibiotics only when prescribed and complete the full course.
  • Adhere to strict infection control measures in healthcare environments (e.g., contact precautions for infected patients).
View Live Alerts

Track Vancomycin-intermediate Staphylococcus aureus and 200+ other diseases with personalized alerts

Expert Resources & References

Trusted information from leading health organizations

CDC

Official guidance from the U.S. Centers for Disease Control and Prevention

View CDC Resources โ†’

WHO

Global disease surveillance and guidelines from the World Health Organization

View WHO Resources โ†’

Research

Latest peer-reviewed research and clinical studies

View Research โ†’

Medically Reviewed Content

Disease information on Virus Watcher is reviewed by our Chief Epidemiologist, a former CDC lead analyst for FluSight forecasting. Outbreak data is aggregated from verified sources including BEACON, ProMED, WHO, CDC, and 50+ national health agencies. This information is for educational purposes and should not replace professional medical advice.

Last reviewed: 2026-06-03

Stay Ahead of Vancomycin-intermediate Staphylococcus aureus Outbreaks

Get real-time alerts and intelligence on Vancomycin-intermediate Staphylococcus aureus and 200+ other diseases. Used by healthcare systems, EMS, schools, and travelers worldwide.

๐Ÿ“ฑ iOS App Temporarily Unavailable

We're working with Apple to restore our app to the App Store.

Get notified when it's back:
Email [email protected] (subject: REMINDER) or check back in a few days.

Download App
Temporarily Unavailable
Download App Enterprise Solutions